Skip to main content
Top
Published in: Head and Neck Pathology 1/2011

01-03-2011 | Proceedings of the NASHNP Companion Meeting, February, 2011, San Antonio, TX

Papillary Thyroid Carcinoma Variants

Authors: Ricardo V. Lloyd, Darya Buehler, Elham Khanafshar

Published in: Head and Neck Pathology | Issue 1/2011

Login to get access

Abstract

Papillary thyroid carcinomas are the most common thyroid cancers and constitute more than 70% of thyroid malignancies. The most common etiologic factor is radiation, but genetic susceptibility and other factors also contribute to the development of papillary thyroid carcinoma. The most common variants include conventional, follicular variant and tall cell variant. However, many other uncommon variants have been described including oncocytic, columnar cell, diffuse sclerosing and solid forms. Immunohistochemical staining with TTF-1 and thyroglobulin is very useful in confirming the diagnosis of papillary thyroid carcinoma especially in metastatic sites. Markers such as HBME-1 and CITED1 can assist in separating some difficult cases of follicular variants of papillary thyroid carcinomas from follicular adenomas. Molecular studies have shown that the BRAF V600E mutation is found mainly in papillary and anaplastic thyroid carcinomas. Other molecular markers such as HMGA2 and insulin-like growth factor II mRNA binding protein 3 have been used recently as molecular tests to separate papillary thyroid carcinoma and its variants from follicular adenomas and other benign thyroid nodules.
Literature
1.
go back to reference Khan A, Nose V. In: Lloyd RV, editor. Endocrine pathology: differential diagnosis and molecular advances, 2nd ed. New York: Springer 2010; p. 181–236. Khan A, Nose V. In: Lloyd RV, editor. Endocrine pathology: differential diagnosis and molecular advances, 2nd ed. New York: Springer 2010; p. 181–236.
2.
go back to reference DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. Pathology and genetics of tumours of endocrine organs. In: Kleihues P, Sobrin LH, series editors. World health organization. Classification of Tumours. Lyon: IARC Press; 2004. DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. Pathology and genetics of tumours of endocrine organs. In: Kleihues P, Sobrin LH, series editors. World health organization. Classification of Tumours. Lyon: IARC Press; 2004.
3.
go back to reference Hemminiki K, Li X. Familial risk of cancer by site and histopathology. Int J Cancer. 2003;103:105–9.CrossRef Hemminiki K, Li X. Familial risk of cancer by site and histopathology. Int J Cancer. 2003;103:105–9.CrossRef
4.
go back to reference Isaacs JD, Lundgren CI, Sidhu SB, et al. The Delphian lymph node in thyroid cancer. Ann Surg. 2008;247:477–82.CrossRefPubMed Isaacs JD, Lundgren CI, Sidhu SB, et al. The Delphian lymph node in thyroid cancer. Ann Surg. 2008;247:477–82.CrossRefPubMed
5.
go back to reference Wallander M, Layfield LJ, Jarboe E, et al. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts. Appl Immunohistochem Mol Morphol. 2010;18:231–5.CrossRefPubMed Wallander M, Layfield LJ, Jarboe E, et al. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts. Appl Immunohistochem Mol Morphol. 2010;18:231–5.CrossRefPubMed
6.
go back to reference Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336–40.CrossRefPubMed Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336–40.CrossRefPubMed
7.
go back to reference Rivera M, Ricarte-Filho J, Patel S, et al. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopthologic and molecular study. Hum Pathol. 2010;41:172–80.CrossRefPubMed Rivera M, Ricarte-Filho J, Patel S, et al. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopthologic and molecular study. Hum Pathol. 2010;41:172–80.CrossRefPubMed
8.
go back to reference Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q. 1976;43:207–15.PubMed Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q. 1976;43:207–15.PubMed
9.
go back to reference Johnson TL, Lloyd RV, Thompson NW, et al. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol. 1988;12:22–7.CrossRefPubMed Johnson TL, Lloyd RV, Thompson NW, et al. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol. 1988;12:22–7.CrossRefPubMed
10.
go back to reference Herrera MF, Hay ID, Wu PS, et al. Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg. 1992;16:669–74.CrossRefPubMed Herrera MF, Hay ID, Wu PS, et al. Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg. 1992;16:669–74.CrossRefPubMed
11.
go back to reference Evans HL. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol. 1986;85:77–80.PubMed Evans HL. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol. 1986;85:77–80.PubMed
12.
go back to reference Koo JS, Hong S, Park CS. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young. Thyroid. 2009;19:1225–31.CrossRefPubMed Koo JS, Hong S, Park CS. Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young. Thyroid. 2009;19:1225–31.CrossRefPubMed
13.
go back to reference Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010;34:44–52.CrossRefPubMed Asioli S, Erickson LA, Sebo TJ, et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic immunohistochemical, and molecular study of eight cases. Am J Surg Pathol. 2010;34:44–52.CrossRefPubMed
14.
go back to reference Kakudo K, Tang W, Ito Y, et al. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol. 2004;10:1041–6.CrossRef Kakudo K, Tang W, Ito Y, et al. Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. J Clin Pathol. 2004;10:1041–6.CrossRef
15.
go back to reference Nassar H. Carcinomas with micropapillary morphology: clinical significance and current concepts. Adv Anat Pathol. 2004;11:297–303.CrossRefPubMed Nassar H. Carcinomas with micropapillary morphology: clinical significance and current concepts. Adv Anat Pathol. 2004;11:297–303.CrossRefPubMed
16.
go back to reference Albores-Saavedra J, Hernandez M, Sanchez-Sosa S, et al. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions. Am J Surg Pathol. 2007;31:729–36.CrossRefPubMed Albores-Saavedra J, Hernandez M, Sanchez-Sosa S, et al. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions. Am J Surg Pathol. 2007;31:729–36.CrossRefPubMed
17.
go back to reference Scognamiglio T, Hyjek E, Kao J, Chen YT. Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol. 2006;126:700–8.CrossRefPubMed Scognamiglio T, Hyjek E, Kao J, Chen YT. Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol. 2006;126:700–8.CrossRefPubMed
18.
go back to reference Nikiforova MN, Nikiforov YE. Molecular genetics of thyroid cancer: implications for diagnosis treatment and prognosis. Expert Rev Mol Diagn. 2008;8:83–95.CrossRefPubMed Nikiforova MN, Nikiforov YE. Molecular genetics of thyroid cancer: implications for diagnosis treatment and prognosis. Expert Rev Mol Diagn. 2008;8:83–95.CrossRefPubMed
19.
go back to reference Lappinga PJ, Kip NS, Jin L, et al. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules. Cancer Cytopathol. 2010;118:287–97.CrossRefPubMed Lappinga PJ, Kip NS, Jin L, et al. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules. Cancer Cytopathol. 2010;118:287–97.CrossRefPubMed
20.
go back to reference Jin L, Seys AR, Zhang S, et al. Diagnostic utility of IMP3 expression in thyroid neoplasms: a quantitative RT-PCR study. Diagn Mol Pathol. 2010;19:63–9.CrossRefPubMed Jin L, Seys AR, Zhang S, et al. Diagnostic utility of IMP3 expression in thyroid neoplasms: a quantitative RT-PCR study. Diagn Mol Pathol. 2010;19:63–9.CrossRefPubMed
Metadata
Title
Papillary Thyroid Carcinoma Variants
Authors
Ricardo V. Lloyd
Darya Buehler
Elham Khanafshar
Publication date
01-03-2011
Publisher
Springer US
Published in
Head and Neck Pathology / Issue 1/2011
Electronic ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-010-0236-9

Other articles of this Issue 1/2011

Head and Neck Pathology 1/2011 Go to the issue

Sine qua none Radiology-Pathology

Squamous Odontogenic Tumor

Proceedings of the NASHNP Companion Meeting, February, 2011, San Antonio, TX

A Review of NUT Midline Carcinoma